|
Press Releases |
|
![](http://www.acnnewswire.com/images/company/Oculis.jpg) |
|
Tuesday, September 6, 2022 |
|
Oculis announces publication of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema |
Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the Phase 2 DX-211, a randomized, double blinded, multi-center and vehicle controlled clinical trial assessing the safety and efficacy of topical OCS-01 in patients with Diabetic Macular Edema (DME) (NCT05343156) has been published by the Acta Ophthalmologica journal. more info >> |
|
Tuesday, August 23, 2022 |
|
Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease |
Oculis S.A., ('Oculis') a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the results of the double blinded more info >> |
|
Wednesday, June 29, 2022 |
|
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery |
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations more info >> |
|
Wednesday, March 2, 2022 |
|
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics |
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, and Accure Therapeutics, a private translational neuroscience R&D company more info >> |
|
Tuesday, February 8, 2022 |
|
Oculis appoints Dr. Bastian Dehmel as Chief Development Officer |
Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the further strengthening of the Company's executive leadership team with the appointment of Dr. Bastian Dehmel as global Chief Development Officer more info >> |
|
Wednesday, January 5, 2022 |
|
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) |
Oculis S.A. ("Oculis"), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, announces the appointment of Mr. Webb Ding as global Chief Operating Officer and General Manager, China, with effect from February 1, 2022. more info >> |
|
|
|
|
|
|
|
|
![](/images/space.gif) |
Latest Press Releases |
![](/images/space.gif) |
Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area
Dec 19, 2024 09:30 HKT/SGT
|
|
|
TechGALA 2025 - Aichi's First International Startup Conference
Dec 19, 2024 09:20 HKT/SGT
|
|
|
American Wave Machines Announces Partnership with China Tourism Group
Dec 19, 2024 09:10 HKT/SGT
|
|
|
GENERALIFX Unveils Multimillion-Dollar AI Strategy Autopilot to Revolutionize Trading
Dec 19, 2024 08:50 HKT/SGT
|
|
|
Q2 Metals Announces Final Analytical Results from the 2024 Drill Campaign at the Cisco Lithium Property, James Bay, Quebec, Canada, and Proceeds of $1.9 Million from Warrant Exercises
Dec 19, 2024 08:40 HKT/SGT
|
|
|
Winvest Group Limited Stock Leaves the Pink And Makes the Leap to OTCQB
Dec 19, 2024 08:00 HKT/SGT
|
|
|
The finest places to live, work, and thrive in Asia are celebrated at the 19th PropertyGuru Asia Property Awards Grand Final
Dec 19, 2024 08:00 HKT/SGT
|
|
|
Honda Presents Next-generation e:HEV Technologies at Press Briefing on Honda e:HEV Business and Technology
Dec 18, 2024 17:50 JST
|
|
|
MHI Appoints CTO Eisaku Ito as Next President & CEO, Announces Changes in Board and Executive-level Personnel
Dec 18, 2024 17:38 JST
|
|
|
Honda to Utilize Existing Powertrain Unit Factory to Establish New Production Plant for Next-generation Fuel Cell System in Japan
Dec 18, 2024 17:22 JST
|
|
|
NEC Receives Telecom Review's Global Excellence Award for Innovative Telecom B2B/ Enterprise Network Solutions
Dec 18, 2024 17:12 JST
|
|
|
Q2 Metals Announces Closing of the Acquisition of Additional Claims at the Cisco Lithium Property, James Bay, Quebec, Canada
Dec 18, 2024 16:05 HKT/SGT
|
|
|
Japan's Telecommunications Carriers Join Forces to Strengthen Disaster Response
Dec 18, 2024 16:11 JST
|
|
|
Toyota's Fuel Cell and Water Electrolysis System Production Plan Certified as a METI Support Program for Building GX Supply Chains
Dec 18, 2024 13:51 JST
|
|
|
ASEAN Ceramics & ASEAN Stone 2024 Reaches New Heights with Record-Breaking Visitor Turnout
Dec 18, 2024 11:50 HKT/SGT
|
|
|
|
More Press release >> |
|
|
![](/images/space.gif) |
![](/images/space.gif) |
![](/images/space.gif) |
|
|